Dyke P McEwen

 Dyke Mcewen
Research Assistant Professor
Pharmacology
Medical School
Office:
University of Michigan
Pharmacology
1150 W. Medical Center Drive
Ann Arbor, MI 48109-0632
Email:
[email protected]
Available to mentor
Dyke P McEwen
Dyke Mcewen
Research Assistant Professor
  • Qualifications
  • Recent Publications

  • Manage Your Profile

    • Qualifications
    • Research Fellow
      University of Michigan, Pharmacology, Ann Arbor, United States
      2006 - 2008
      Postdoctoral Fellowship
    • Research Fellow
      University of Colorado Health Sciences Center, Cell Biology, Aurora, United States
      2004 - 2005
      Postdoctoral Fellowship
    • PhD
      University of Michigan, Ann Arbor, United States
      1998 - 2004
    • BA, Chemistry/Biology
      Kalamazoo College, Kalamazoo, United States
      1994 - 1998

    Recent Publications

     See All Publications
    • Journal Article
      PD05.08. T-Cell Inactivation in Esophageal Adenocarcinoma Is Mediated by ISG15 Related CD3 Loss
      Lagisetty K, Savitch S, Ray D, McEwen D, Ray P. Diseases of the Esophagus, 2026 Aug 23; 39 (Supplement_1): doag077.111 DOI:10.1093/dote/doag077.111
    • Preprint
      Immunogenicity evaluation of mutant peptides identified from lung cancer patients
      Yang J, Xin Y, Liu J, McEwen DP, Gensterblum-Miller E, Chang AE, Liu Q, Li X, Brenner JC, Liu J, Chang AC, Li Q. 2026 Aug 22; Research Square, DOI:10.21203/rs.3.rs-10635382/v1
    • Journal Article
      ISG15/GRAIL1/CD3 axis influences survival of patients with esophageal adenocarcinoma
      McEwen DP, Ray P, Nancarrow DJ, Wang Z, Kasturirangan S, Abdullah S, Balan A, Hoskeri R, Thomas D, Lawrence TS, Beer DG, Lagisetty KH, Ray D. Jci Insight, 2024 Jan 1; 9 (13): DOI:10.1172/jci.insight.179315
      PMID: 38781019
    • Journal Article
      Factors affecting timing of surgery following neoadjuvant chemoradiation for esophageal cancer
      Jiang SJ, Diaconescu AC, McEwen DP, McEwen LN, Chang AC, Lin J, Reddy RM, Lynch WR, Bonner S, Lagisetty KH. Heliyon, 2023 Dec 1; 9 (12): DOI:10.1016/j.heliyon.2023.e23212
    • Proceeding / Abstract / Poster
      139 Identifying neoantigens in lung adenocarcinoma patients
      Chang AC, Xin Y, Issabekova A, McEwen D, Gensterblum-Miller E, Chad Brenner J, Dobson H, Chang AE, Li Q. 2023 Nov 2; a159 - a159. DOI:10.1136/jitc-2023-sitc2023.0139
    • Journal Article
      Role of IL4 and GMCSF in Predicting Survival in Esophageal Cancer
      Rebernick RJ, Bell HN, Bauer TM, McEwen D, Werkman DF, Chang AC, Lin J, Reddy RM, Kresty L, Lagisetty K. Journal of the American College of Surgeons, 2023 Jan 1; 236 (1): 107 - 115. DOI:10.1097/XCS.0000000000000446
      PMID: 36519914
    • Proceeding / Abstract / Poster
      Interleukin 4 levels predict survival independently of pathologic stage in a mixed esophageal cancer cohort
      Rebernick R, Bauer T, McEwen D, Chang AC, Lin J, Reddy R, Lynch W, Wakeam W, Kresty L, Lagisetty K. 2022 Oct 16;
    • Proceeding / Abstract / Poster
      Proanthocyanidins enhance chemotherapy-induced esophageal adenocarcinoma cell death
      Zhang Y, Weh K, Howard C, Lagisetty K, McEwen D, Lin J, Reddy RM, Chang A, Beer DG, Howell A, Kresty LA. Cancer Research, 2021 Apr 10; 81 (13_Supplement): 1418 - 1418. DOI:10.1158/1538-7445.am2021-1418